Aggressive CD30 Large Cell Lymphoma after Cyclosporine Given for Putative Atopic Dermatitis | Citedby Results | Dermatology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Aggressive CD30 Large Cell Lymphoma after Cyclosporine Given for Putative Atopic Dermatitis

Dermatology (2006) 213 (3): 239–241.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Dupilumab, Atopic Dermatitis, and Mycosis Fungoides—New Insights on an Evolving Story

Joan Guitart

JAMA Dermatology (2023) 159 (11): 1177.

Transformation of atopic dermatitis into T-cell lymphoma of the skin: myth or reality?

I.E. Belousova
E.V. Matushevskaya

Klinicheskaya dermatologiya i venerologiya (2020) 19 (2): 149.

Follicular Eruption With Folliculotropic Lymphocytic Infiltrates Associated With Iatrogenic Immunosuppression: Report and Study of 3 Cases, and Review of the Literature

Emily Avitan-Hersh
David Dias-Polak
Michal Ramon
Dvora Sahar
Daniella Magen
Shirley Pollack
Reuven Bergman

The American Journal of Dermatopathology (2020) 42 (7): 498.

Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders, Diffuse Large B-Cell Lymphoma Type, in a Patient with Behçet’s Disease Treated with Cyclosporine A

Yuka Urano
Rintaro Ohe
Akane Yamada
Takanobu Kabasawa
Kazushi Suzuki
Takumi Kitaoka
Nobuyuki Tamazawa
Naing Ye Aung
Aya Utsunomiya
Tomomi Toubai
Kenichi Ishizawa

Case Reports in Oncology (2020) 13 (3): 1145.

British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018

J. Berth‐Jones
L.S. Exton
E. Ladoyanni
M.F. Mohd Mustapa
V.M. Tebbs
P.D. Yesudian
N.J. Levell
P.M. McHenry
T.A. Leslie
S. Wakelin
R.Y.P. Hunasehally
M. Cork
G.A. Johnston
N. Chiang
F.S. Worsnop
A. Salim
D. Buckley
G. Petrof
N. Callachand
T. Flavell
A.A. Salad

British Journal of Dermatology (2019) 180 (6): 1312.

Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy

Masahiro Ohara
Kokoro Ozaki
Takuya Ohkubo
Akane Yamada
Yoshiyuki Numasawa
Keisuke Tanaka
Shohei Tomii
Satoru Ishibashi
Nobuo Sanjo
Takanori Yokota

Internal Medicine (2018) 57 (4): 601.

Progression of undiagnosed cutaneous lymphoma after anti–tumor necrosis factor-alpha therapy

Maria Estela Martinez-Escala
Alba L. Posligua
Heather Wickless
Audrey Rutherford
Kimberly A. Sable
Belen Rubio-Gonzalez
Xiaolong A. Zhou
Jason B. Kaplan
Barbara Pro
Jaehyuk Choi
Christiane Querfeld
Steven T. Rosen
Joan Guitart

Journal of the American Academy of Dermatology (2018) 78 (6): 1068.

Unmasking mycosis fungoides/Sézary syndrome from preceding or co-existing benign inflammatory dermatoses requiring systemic therapies: patients frequently present with advanced disease and have an aggressive clinical course

S.H. Foo
F. Shah
S. Chaganti
A. Stevens
J.J. Scarisbrick

British Journal of Dermatology (2016) 174 (4): 901.

Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis

Laureline Legendre
Thomas Barnetche
Juliette Mazereeuw-Hautier
Nicolas Meyer
Dedee Murrell
Carle Paul

Journal of the American Academy of Dermatology (2015) 72 (6): 992.

A case of primary cutaneous anaplastic large cell lymphoma in association with atopic dermatitis -Literature analysis of 16 reported cases-

Hiroko SASANO
Takashi YOSHIIKE
Michiaki KOIKE
Shin TANAKA

Skin Cancer (2015) 30 (2): 123.

Optimized Nonclinical Safety Assessment Strategies Supporting Clinical Development of Therapeutic Monoclonal Antibodies Targeting Inflammatory Diseases

Frank R. Brennan
Annick Cauvin
Jay Tibbitts
Alison Wolfreys

Drug Development Research (2014) 75 (3): 115.

Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology

Matthew W. Muellenhoff
John Y. Koo

Journal of Dermatological Treatment (2012) 23 (4): 290.

Current awareness: Pharmacoepidemiology and drug safety

Pharmacoepidemiology and Drug Safety (2007) 16 (5)